China's vaccine developers stuck with unused mRNA COVID-19 shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a lack of revenue.
About the Author
China's vaccine developers stuck with unused mRNA COVID-19 shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a lack of revenue.
